Gansulin 50r insulin is known generically as 50/50 Mixed Recombinant Human Insulin Injection and is not long acting. 50/50 Mixed Recombinant Human Insulin Injection is mainly used in the treatment of diabetes mellitus.50/50 Mixed Recombinant Human Insulin Injection is an insulin preparation made of short-acting insulin and intermediate-acting insulin in a ratio of 50%:50%.This pre-mixed insulin preparation can only be used for subcutaneous injections, not for intravenous injections or for insulin pump therapy. The short-acting component of premixed insulin preparation has a rapid onset of action and can better control postprandial hyperglycemia, while the intermediate-acting component continues to be released slowly, mainly replacing basal insulin secretion. The advantage is that it is easy to use, the number of injections is relatively small, and the operation is not complicated; the disadvantage is that because it is pre-mixed, it is difficult to meet some special mixing requirements. The onset of action of 50/50 mixed recombinant human insulin injection is about 30 minutes, the maximum concentration time is about 2~8 hours, the duration of action is about 10~24 hours, it is not long-acting. Contraindicated in hypoglycemia, insulin allergy; adverse reactions include local redness, swelling, itching, generalized rash, shortness of breath, etc.; note that the use of 50/50 Mixed Recombinant Human Insulin Injection requires monitoring of blood glucose, and it should be stored at a temperature of 2~8℃. 50/50 mixed recombinant human insulin injection medication need to follow the doctor’s instructions, do not adjust the drug without authorization.